VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $12.23 million. The enterprise value is -$20.71 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 33.29 million shares outstanding. The number of shares has increased by 7.39% in one year.
| Current Share Class | 33.29M |
| Shares Outstanding | 33.29M |
| Shares Change (YoY) | +7.39% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 15.31% |
| Float | 32.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.36 |
| Forward PS | 23.52 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.87
| Current Ratio | 8.87 |
| Quick Ratio | 8.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.67% and return on invested capital (ROIC) is -48.70%.
| Return on Equity (ROE) | -70.67% |
| Return on Assets (ROA) | -41.51% |
| Return on Invested Capital (ROIC) | -48.70% |
| Return on Capital Employed (ROCE) | -116.24% |
| Revenue Per Employee | $40,308 |
| Profits Per Employee | -$2.59M |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VYNE has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.75% in the last 52 weeks. The beta is 2.01, so VYNE's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | -86.75% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 49.32 |
| Average Volume (20 Days) | 1,671,267 |
Short Selling Information
The latest short interest is 855,488, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 855,488 |
| Short Previous Month | 796,916 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 2.60% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, VYNE had revenue of $524,000 and -$33.67 million in losses. Loss per share was -$0.79.
| Revenue | 524,000 |
| Gross Profit | 524,000 |
| Operating Income | -37.30M |
| Pretax Income | -33.79M |
| Net Income | -33.67M |
| EBITDA | n/a |
| EBIT | -37.30M |
| Loss Per Share | -$0.79 |
Full Income StatementBalance Sheet
The company has $32.70 million in cash and n/a in debt, giving a net cash position of $32.70 million or $0.98 per share.
| Cash & Cash Equivalents | 32.70M |
| Total Debt | n/a |
| Net Cash | 32.70M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 32.09M |
| Book Value Per Share | 1.01 |
| Working Capital | 31.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.36 million and capital expenditures -$117,000, giving a free cash flow of -$38.48 million.
| Operating Cash Flow | -38.36M |
| Capital Expenditures | -117,000 |
| Free Cash Flow | -38.48M |
| FCF Per Share | -$1.16 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -7,118.32% |
| Pretax Margin | -6,447.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.39% |
| Shareholder Yield | -7.39% |
| Earnings Yield | -280.73% |
| FCF Yield | -320.82% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 152.08% |
| EPS Growth Forecast (5Y) | 23.65% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
VYNE has an Altman Z-Score of -27.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.51 |
| Piotroski F-Score | 1 |
